FDA is investigating Sarepta's Elevidys after two deaths from liver failure in non-ambulatory DMD patients, raising safety ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is one of the 10 Worst Aggressive Growth Stocks to Buy According to Short Sellers.

HC Wainwright & Co. analyst Mitchell Kapoor downgraded Sarepta Therapeutics, Inc. SRPT from Neutral to Sell and lowered the ...

Fintel reports that on June 25, 2025, HC Wainwright & Co. downgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $72.34, a high estimate of $183.00 ...

In the closing of the recent trading day, Wingstop (WING) stood at $364.11, denoting a +1.09% move from the preceding trading day.

Intuitive Machines, Inc. (NASDAQ:LUNR) is one of the 13 Small Cap Stocks Analysts Are Bullish On. On May 22, Barclays ...

The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver ...

Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the best mid cap growth stocks to invest in now. Earlier on June 4, Sarepta ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is one of the Massive Sell-Offs: These 10 Stocks Shockingly Nosedived. Sarepta ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Wolfe Research ...